296 Emerging evidence has proven that SGLT-is can reduce the risk of adverse cardiovascular outcomes
Transient expression of IL-1 induces acute lung injury and chronic lung repair, leading to pulmonary fibrosis
10.1016/j.neuropharm.2024.109929 41 HuangY.LiuJ.HeJ.HuZ.TanF.ZhuX.et al (2022)
CrossRef GLP-1 agonists and changes in body mass and composition in adults with overweight or obesity with or without type 2 diabetes mellitus: a systematic review and meta-analysis Nadia Sawicka-Gutaj, Dawid Gruszczyski, Kacper Nijakowski, Aleksandra Derwich-Rudowicz, Michal Krenz, Anita Kumar, Pei-Yin Lu, Marek Ruchaa International Journal of Obesity.2026;[Epub] CrossRef Metabolic DysfunctionAssociated Steatotic Liver Disease and Obesity: Pathogenesis, Diagnostics, Risk Stratification, and Therapeutic Approach Beom Kyung Kim The Kaohsiung Journal of Medical Sciences.2026;[Epub] CrossRef Intravenous contrast medium impairs CT-based muscle quality but not quantity assessment: a translational study Luca Salhfer, Gregor Jost, Mathias Holtkamp, Jannis Straus, Marcel Opitz, Sebastian Zensen, Rene Hosch, Johannes Harmes, Lale Umutlu, Michael Forsting, Felix Nensa, Hubertus Pietsch, Johannes Haubold Frontiers in Radiology.2026;[Epub] CrossRef Nanotechnology-enabled targeted delivery of incretin therapies for the treatment of obesity and metabolic disorders Daniel Ejim Uti, Josephine E
Less liquid under the skin means less chance of irritation at the injection site
